China SXT Pharmaceuticals Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Monitoring Framework
Key Performance Indicators
Annual Revenue Annually1.1M
Net Loss Annually-3.3M
Cash and Cash Equivalents Annually18.1M
Watch Items
- Nasdaq Minimum Bid Price ComplianceTrigger: Closing bid price below $1.00 for 30 consecutive business daysAction: Implement share consolidation (reverse stock split) or other capital restructuring to regain compliance.
- Shareholder Dilution from Capital OfferingsTrigger: Issuance of Class A Ordinary Shares under the $100,000,000 At-The-Market (ATM) Sales AgreementAction: Monitor outstanding share count and pro forma net tangible book value per share.
Research as of 20 Jun 2026